Group 1 - The core point of the article highlights the performance and holdings of the Guangfa Healthcare Stock A fund, which has a recent net value of 1.8385 yuan, reflecting a decline of 1.37% [1] - The fund's performance over the past month shows a return of 4.59%, ranking 34 out of 316 in its category; over the past six months, it has returned 11.72%, ranking 41 out of 311; and since the beginning of the year, it has achieved a return of 13.74%, ranking 36 out of 311 [1] - The top ten holdings of the fund account for a total of 48.15%, with significant positions in companies such as Zai Lab (10.52%), Kelun Pharmaceutical (8.39%), and others [1] Group 2 - Guangfa Healthcare Stock A fund was established on August 10, 2017, and as of March 31, 2025, it has a total scale of 5.237 billion yuan, managed by fund manager Wu Xingwu [1] - Wu Xingwu has a background in finance with a master's degree in science and has held various positions in fund management, including roles at Morgan Stanley Huaxin Fund Management and Guangfa Fund Management [2]
6月19日广发医疗保健股票A净值下跌1.37%，近1个月累计上涨4.59%
Sou Hu Cai Jing·2025-06-19 12:05